Skip to Content

Tag: Diabetes


Also Noted

Ascensia extends PASS program

March 14, 2024HME News Staff

PARSIPPANY, N.J. – Ascensia Diabetes Care and Senseonics Holdings will extend the Eversense Payment Assistance and Simple Savings (PASS) Program. Designed to help people in the U.S. access the Eversense E3 CGM System more affordably, the program offers major savings for eligible individuals looking to experience the unique benefits of the only long-term CGM system available. Eligible individuals will pay only $99 out of pocket for an unlimited number of six-month Eversense E3 systems under...

Ascensia Diabetes Care, Continuous Glucose Monitor (CGM), Diabetes, Eversense, Senseonics


Read Full Articlered right arrow icon

Arti Masturzo

Specialty Providers

CCS ‘on right track’ 

March 13, 2024Theresa Flaherty, Managing Editor

GLP-1 medications misconception: Nearly 60% of diabetes patients surveyed by CCS mistakenly believe that GLP-1 medications alone are a silver bullet for managing their health. However, these drugs need to be integrated into a long-term holistic care plan.  Education and support gap: The survey results highlight a real need for better education and support for patients managing their diabetes. Diabetes suppliers are well-positioned to...

CCS, Coaching, Diabetes, Education, GLP-1


Read Full Articlered right arrow icon

News

In brief: AAH on cath fraud & CCS on GLP-1s

March 8, 2024HME News Staff

WASHINGTON – AAHomecare has issued a statement affirming its support for the government to implement real-time monitoring of claims to detect potential fraud and abuse, in response to news reports of potential Medicare fraud by a handful of intermittent catheter companies.  AAHomecare's statement, which was shared with CMS and Capitol Hill, also reiterates recommendations for federal government initiatives to better monitor DME supplier billing practices and trends, including:  Increased...

AAHomecare, Catheter, CCS, Diabetes, Noridian Healthcare Solutions, Soleo Health


Read Full Articlered right arrow icon

Arti Masturzo

Specialty Providers

CCS survey: Education lacking for diabetes

March 7, 2024HME News Staff

DALLAS – CCS engaged independent market research firm PureSpectrum to survey more than 1,500 people living with diabetes to understand their attitude on an array of timely issues, including growing demand for GLP-1 weight loss drugs.  The survey found 57% of people with diabetes think GLP-1 weight loss drugs alone may be a silver bullet for helping achieve their health goals.  “GLP-1 weight loss drugs alone are not a silver bullet when it comes to improving the health...

CCS, Diabetes, GLP-1


Read Full Articlered right arrow icon

Also Noted

Dexcom to introduce OTC glucose sensor

March 6, 2024HME News Staff

SAN DIEGO – Dexcom has received clearance from the U.S. Food and Drug Administration for its Stelo by Dexcom, a continuous glucose monitor that will be available for people with Type 2 diabetes without a prescription. “Dexcom continues to lead innovation in the CGM market, with a long list of first-in-market advances,” said Jake Leach, executive vice president and COO. “Dexcom was the first to connect CGM to multiple insulin delivery devices, the first to connect CGM to a...

Continuous Glucose Monitor (CGM), Dexcom, Diabetes, Stelo


Read Full Articlered right arrow icon

Also Noted

Know Labs unveils non-invasive CGM

February 29, 2024HME News Staff

SEATTLE – Know Labs, an emerging developer of non-invasive medical diagnostic technology, has unveiled KnowU, a wearable non-invasive continuous glucose monitor (CGM), the result of an accelerated development process over the last eight months. The KnowU incorporates the sensor that the company plans to submit to the U.S. Food and Drug Administration for clearance. “The prevalence of diabetes is growing globally at an alarming rate,” said Ron Erickson, CEO and chairman. “Millions...

Continuous Glucose Monitor (CGM), Diabetes, Know Labs


Read Full Articlered right arrow icon

Also Noted

Insulet’s Omnipod fuels growth

February 23, 2024HME News Staff

ACTON, Mass. – Insulet reported full year 2023 revenues $1.7 billion, up 30% compared to 2022. Fourth quarter 2023 revenue was $509.8 million, up nearly 38%. Total Omnipod revenue was $501 million; of that, US Omnipod revenue was $394.6 million, an increase of nearly 43%. “2023 was another transformational year for Insulet,” said Jim Hollingshead, president & CEO. “The rapid adoption of Omnipod 5 helped fuel our eighth consecutive year of more than 20% constant currency revenue...

Diabetes, Insulet, Insulin pump, Omnipod


Read Full Articlered right arrow icon

Advanced Diabetes Supply builds out C-suite 

Specialty Providers

Advanced Diabetes Supply builds out C-suite 

January 22, 2024HME News Staff

CARLSBAD, Calif. - Advanced Diabetes Supply, a distributor of specialized diabetes devices under the ADS and USMED brands, has made three new C-suite appointments.  The company has named Sean Muiz as chief supply chain officer, Melanie Montero as revenue cycle leader and Walt Meffert as chief transformation officer.  “We are pleased to welcome these seasoned leaders to the ADS executive team,” said Bill Mixon, who was named ADS CEO last year. “Their experience, expertise...

Advanced Diabetes Supply, Diabetes, Supplies, US MED


Read Full Articlered right arrow icon

Kattrina Richardson

Specialty Providers

Edgepark stands up new team to educate physicians

January 19, 2024Theresa Flaherty, Managing Editor

DUBLIN, Ohio – Edgepark has “leaned into” a new prescriber base for continuous glucose monitors by creating a Provider Engagement Team to drive positive experiences for those new to the technology.   CMS’s decision last year to expand coverage to beneficiaries with Type 2 diabetes created a huge potential of referrals from primary care physicians who need to be brought up to speed on the therapy, says Kattrina Richardson, vice president of marketing and business...

Continuous Glucose Monitor (CGM), Diabetes, Edgepark


Read Full Articlered right arrow icon

Also Noted

Omada Health to offer diabetes service through Amazon Health Services

January 11, 2024HME News Staff

SAN FRANCISCO – Omada Health, a virtual health care provider, has announced a partnership with Amazon Health Services to increase awareness of its cardiometabolic programs through Amazon’s new Health Condition Programs. Omada will be the first virtual diabetes prevention, diabetes and hypertension provider available in Amazon’s Health Condition Programs, helping individuals discover and enroll in virtual care benefits that are available to them through their employer or health plan...

Amazon Health Services, Diabetes, Omada Health


Read Full Articlered right arrow icon